| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/26/2012 | US20120022034 Methods for reducing or neovascularization or edema |
| 01/26/2012 | US20120022030 Tetracyclic Lactame Derivatives |
| 01/26/2012 | US20120022018 Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment |
| 01/26/2012 | US20120022009 Tannate dry powder formulations |
| 01/26/2012 | US20120022006 B-lymphocyte stimulator binding polypeptides and methods based thereon |
| 01/26/2012 | US20120022004 Treatment of t-cell mediated diseases |
| 01/26/2012 | US20120022003 Method of using diketopiperazines and composition containing them |
| 01/26/2012 | US20120022001 Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
| 01/26/2012 | US20120021993 Protein scaffold library based on kringle domain structure and uses thereof |
| 01/26/2012 | US20120021988 Methods for treating immune thrombocytopenia |
| 01/26/2012 | US20120021470 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 01/26/2012 | US20120021079 Garcinia Mangostana L. and Iridoid Based Formulations |
| 01/26/2012 | US20120021061 Medical and nutritional formulations |
| 01/26/2012 | US20120021056 Methods and Systems for Inducing Immunologic Tolerance to Non-Self Antigens |
| 01/26/2012 | US20120021043 Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant |
| 01/26/2012 | US20120021021 Method for preparing pharmaceutical compositions comprising fine particles of active substance |
| 01/26/2012 | US20120021011 Anti-inflammatory pharmaceutical composition comprising extracts from broussonetia papyrifera and lonicera japonica |
| 01/26/2012 | US20120021007 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
| 01/26/2012 | US20120021006 Egfr-homing double-stranded rna vector for systemic cancer treatment |
| 01/26/2012 | US20120021004 Medium and method of deriving and using a mutated bacteria strain |
| 01/26/2012 | US20120021002 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof |
| 01/26/2012 | US20120020998 Plasmacytoid dendritic cell line used in active or adoptive cell therapy |
| 01/26/2012 | US20120020996 Vaccines against clostridium difficile and methods of use |
| 01/26/2012 | US20120020995 Parapoxvirus vectors |
| 01/26/2012 | US20120020994 Multivalent, drying resistant, evolution-based vaccines |
| 01/26/2012 | US20120020993 Vaccine |
| 01/26/2012 | US20120020992 Production of Biologically Active Proteins |
| 01/26/2012 | US20120020991 Prodomain modulators of adam 10 |
| 01/26/2012 | US20120020988 Antibodies specifically binding to human TSLPR and methods of use |
| 01/26/2012 | US20120020987 MHC-Less cells |
| 01/26/2012 | US20120020981 Anti-IL6/IL-6R Antibodies and Methods of Use Thereof |
| 01/26/2012 | US20120020979 METHODS FOR TREATING IgE-MEDIATED DISORDER |
| 01/26/2012 | US20120020973 Chimeric ospa genes, proteins, and methods of use thereof |
| 01/26/2012 | US20120020965 Molecules that bind CD180, compositions and methods of use |
| 01/26/2012 | US20120020964 Antibodies for Norovirus |
| 01/26/2012 | US20120020963 Anti-inteferon alpha monoclonal antibodies and methods for use |
| 01/26/2012 | US20120020962 Method of depleting regulatory t cell |
| 01/26/2012 | US20120020958 Fibcd1 for the prevention and treatment of diseases |
| 01/26/2012 | US20120020957 Dengue virus neutralizing antibodies and use thereof |
| 01/26/2012 | US20120020956 Activation of sodium potassium atpase |
| 01/26/2012 | US20120020955 Detection of Neurological Disorders With Immune Reactions |
| 01/26/2012 | US20120020930 Methods for the preparation of adipose derived stem cells and utilizing said cells in the treatment of diseases |
| 01/26/2012 | US20120020918 Il-1 family variants |
| 01/26/2012 | US20120020916 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/26/2012 | US20120020912 Prostate cancer vaccine |
| 01/26/2012 | US20120020902 Pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppressive action of aggressive agents on the skin |
| 01/26/2012 | US20120020885 MHC-Less cells |
| 01/26/2012 | CA2806362A1 Administration of rifalazil to immunocompromised patients |
| 01/26/2012 | CA2806258A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | CA2806250A1 Cross-protective pathogen protection, methods and compositions thereof |
| 01/26/2012 | CA2805442A1 Methods and compositions for modification of an hla locus |
| 01/26/2012 | CA2804998A1 Peptide compounds for regulating the complement system |
| 01/26/2012 | CA2804914A1 Regulatory immune cells with enhanced targeted cell death effect |
| 01/26/2012 | CA2768866A1 High yield yellow fever virus strain with increased propagation in cells |
| 01/25/2012 | EP2410055A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/25/2012 | EP2409966A1 Aminocyclitol compounds, procedure for the obtainment and uses |
| 01/25/2012 | EP2409706A1 Dihydropteridinones for the treatment of cancer diseases |
| 01/25/2012 | EP2408934A1 Peptidase inhibitor 16 (pi16) as a biomarker for regulatory t (treg) cells and uses thereof |
| 01/25/2012 | EP2408769A1 Pyrimidine derivatives used as itk inhibitors |
| 01/25/2012 | EP2408753A2 Compounds and methods for treating mammalian gastrointestinal microbial infections |
| 01/25/2012 | EP2408473A1 Vaccination methods |
| 01/25/2012 | EP2144623B1 Process for the manufacture of a dairy-based anti-inflammatory composition |
| 01/25/2012 | EP1737477B1 Methods of use of probiotic lactobacilli for companion animals |
| 01/25/2012 | EP1660458B1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/25/2012 | EP1503773B9 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 01/25/2012 | EP1440157B1 Methods and means for producing proteins with predetermined post-translational modifications |
| 01/25/2012 | EP1432991B1 Identification and isolation of somatic stem cells and uses thereof |
| 01/25/2012 | EP1351707B9 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 01/25/2012 | CN1558759B 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 01/25/2012 | CN102333863A Non-embryonic stem cells and uses thereof |
| 01/25/2012 | CN102333858A Immunopotentiating fermented food obtained from fructan-containing food |
| 01/25/2012 | CN102333781A Tricyclic pyrazolopyrimidine derivative |
| 01/25/2012 | CN102333761A Scriptaid isosteres and their use in therapy |
| 01/25/2012 | CN102333539A Recombinant avian-infectious coryza vaccine and method for producing same |
| 01/25/2012 | CN102333530A Ceramide-analogous metabolites |
| 01/25/2012 | CN102329803A Portunus trituberculatus antilipopolysaccharide factor PtALF-6 gene and coding protein and applications thereof |
| 01/25/2012 | CN102329802A Portunus trituberculatus antilipopolysaccharide factor PtALF-4 gene and coding protein and applications thereof |
| 01/25/2012 | CN102329801A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-1 gene, protein encoded by gene and application of protein |
| 01/25/2012 | CN102329781A Anti-human LIGHT monoclonal antibody and application thereof |
| 01/25/2012 | CN102329715A Compound Rhodiola rosea wine and preparation method thereof |
| 01/25/2012 | CN102329325A Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors |
| 01/25/2012 | CN102327587A Chinese herbal medicine for curing chronic or intractable immune thrombocytopenia and preparation method of Chinese medicine preparation |
| 01/25/2012 | CN102327462A Traditional Chinese medicine for treating qi and blood insufficiency asthenia diseases of leukemia patients after chemotherapy and method for preparing traditional Chinese medicine preparations |
| 01/25/2012 | CN102327448A Chinese herbal medicine for treating urticaria |
| 01/25/2012 | CN102327409A Traditional Chinese medicine preparation for detoxication and fat reduction and preparation method thereof |
| 01/25/2012 | CN102327335A Method for extracting total saponins from clematis root |
| 01/25/2012 | CN102327316A Method for extracting total saponins from fructus gleditsiae |
| 01/25/2012 | CN102327315A Drug combination containing astragalus and use thereof |
| 01/25/2012 | CN102327296A Propolis powder and preparation method thereof |
| 01/25/2012 | CN102327292A Refined powder of sheep embryo and sheep placenta and preparation method thereof |
| 01/25/2012 | CN102327291A Stock solution of sheep embryo and sheep placental peptide and preparation method thereof |
| 01/25/2012 | CN102327279A Triptolide and lonicerin compatible medicine composition, preparation and application thereof |
| 01/25/2012 | CN102327276A Injecta for treating bacterial encephalitis of dog and preparation method thereof |
| 01/25/2012 | CN102327267A Pharmaceutical compositions |
| 01/25/2012 | CN102327243A Pidotimod chewable tablet |
| 01/25/2012 | CN102327242A Polyethylene glycol-integrated interferon variant lyophilized preparation |
| 01/25/2012 | CN102327241A Polyethylene glycol-integrated interferon variant freeze-dried preparation |
| 01/25/2012 | CN102327229A Pidotimod dry suspension |
| 01/25/2012 | CN102327227A Preparation method of polyethylene glycol-poly(gamma-amino-epsilon-caprolactone) nano particle loaded with glycyrrhetic acid |
| 01/25/2012 | CN102327220A Solid loratadine lipidosome preparation |